By Paige Maguire Tuesday, August 12, 2014 clinical trial Early Access to Medicine Scheme (EAMS) Merk MK-23475 rambling Moving forward, a surprise and some very good news! It's been another busy week in which we have moved forward on a number of fronts.... ...On the home front, the new garden shed has been ...
By Paige Maguire Thursday, April 10, 2014 clinical trial Early Access to Medicine Scheme (EAMS) EU Clinical Trial Regulation Medical Innovation Bill Mesothelioma Priority Setting Partnership (PSP) Saatchi Bill Selumetanib Vandetanib VanSel1 Mesothelioma - making sense of recent developments April 2014 is shaping up to be a significant month for the mesothelioma community and other people with rare and life threatening diseases. ...
By Paige Maguire Sunday, April 6, 2014 clinical_trial Early Access to Medicine Scheme (EAMS) Saatchi Bill VanSel1 VanSel1 drug trial Cycle 2 Days 16-21 One more dose of selumetanib tonight and Steve will have finished the third week of cycle 2 of the VanSel1 clinical drug trial. Just one mo...
By Paige Maguire Friday, March 28, 2014 Early Access to Medicine Scheme (EAMS) Saatchi Bill Early Access to Medicines Scheme and Medical Innovations (Saatchi) Bill Two exciting developments of particular interest to people with mesothelioma and other life threatening conditions for which there is no cur...
By Paige Maguire Friday, March 21, 2014 Early Access to Medicine Scheme (EAMS) The Early Access to Medicines Scheme (EAMS) Announcement from the UK's Medicines and Healthcare Products Regulatory Agency: " The Early Access to Medicines Scheme (EAMS) aim...